BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Viatronix, Inc Announces the Release of Their 'Enhanced' V3D-Cardiac Module


12/9/2008 7:18:11 AM

STONY BROOK, N.Y., Dec. 8 /PRNewswire/ -- Stony Brook based Viatronix Incorporated (www.viatronix.com), a leading innovator and developer of 3D imaging software, announced today that the Company received FDA 510(k) market clearance for its V3D-Cardiac module.

"The module has been developed utilizing the "proven" Viatronix V3D user friendly interface and workflow. It represents another milestone for the Company delivering a clinical application designed around a physician's workflow," said Zaffar Hayat, CEO and President of Viatronix. In the near future we expect to deliver other organ specific modules to meet the demands of the diagnostic imaging market."

"The V3D-Cardiac module is another achievement that stands by our philosophy of delivering high-end workflow optimized clinical solutions. We worked very closely with physicians to make sure we provided a complete cardiac solution," said Dongqing Chen, Lead Scientist at Viatronix. The V3D-Cardiac application combines left ventricle and coronary analysis functions into a single "user friendly" module. Since both functions are analyzed in a single application, the physician can now choose from any of the multiple phases when performing a coronary analysis. "We built this product based upon the success and strengths of our other V3D clinical applications. They are recognized in the industry for ease of use, intuitive interfaces and multiple toolsets enabling physicians to perform time efficient reads," Dr. Chen added.

In meeting market demands, all of Viatronix's V3D clinical applications are available on an enterprise wide "software only" server based licensing model.

About Viatronix

Viatronix is a leading innovator and developer of 2D/3D medical imaging and diagnostic software. The software enables physicians to interactively view vital organs and anatomical structures within the human body from data acquired by standard medical imaging equipment in minimally or non-invasive methods. Viatronix's user interface is well known for ease of use, efficient workflow and intuitive diagnostic tools.

Viatronix, through application of its V3D(R) technology is developing additional innovative products that will be useful in early detection of other diseases, treatment planning, intervention, and follow-up evaluation. Viatronix, Inc. is located in Stony Brook, NY. To learn more, call us toll free at 1-866-887-4636 or log on to www.viatronix.com.

CONTACT: Susan Levin of Viatronix, +1-631-444-6181, or
susan_pr@viatronix.com



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES